Skip to main content
Top
Published in: BMC Infectious Diseases 1/2015

Open Access 01-12-2015 | Research article

Delay in sputum smear conversion and outcomes of smear-positive tuberculosis patients: a retrospective cohort study in Bafoussam, Cameroon

Authors: Fabrice Nembot Djouma, Michel Noubom, Jérôme Ateudjieu, Hubert Donfack

Published in: BMC Infectious Diseases | Issue 1/2015

Login to get access

Abstract

Background

In limited resource settings, sputum smear conversion at the end of the intensive phase of tuberculosis treatment is an indicator not only of patients’ response to treatment, but also of anti-tuberculosis program performance. The objective of this study was to identify factors associated to sputum smear non-conversion at the end of the intensive phase of treatment, and the effect of smear non-conversion on the outcome of smear-positive pulmonary tuberculosis patients.

Method

This retrospective cohort study was carried out on data of patients treated in the Diagnostic and Treatment Centre of Baleng, West-Cameroon from 2006 to 2012. Logistic regression models were used to evaluate the association of socio-demographic and clinical factors with delay in sputum smear conversion, and the association of this delay with treatment outcomes.

Result

Out of 1425 smear-positive pulmonary tuberculosis patients treated during the study period, 1286 (90.2%) were included in the analysis. Ninety four (7.3% CI: 6.0- 8.9) patients were identified as non-converted at the end of the intensive phase of treatment. Pre-treatment smears graded 2+ and 3+ were independently associated to delay in smear conversion (p < 0.01). Years of treatment ranging from 2009 to 2012 were also associated to delay in smear conversion (p < 0.02). Delay in smear conversion was significantly associated to failure [Adjusted Odd Ratio (AOR):12.4 (Confidence Interval: CI 4.0- 39.0)] and death, AOR: 3.6 (CI 1.5- 9.0).

Conclusion

Heavy initial bacillary load and treatment years ranging from 2009 to2012 were associated to sputum smear non-conversion at the end of the intensive phase of TB treatment. Also, delay in smear conversion was associated to unfavorable treatment outcomes. Patients with heavy initial bacillary load should thus be closely monitored and studies done to identify reasons for the high proportion of non-conversion among patients treated between 2009 and 2012.
Literature
3.
go back to reference Hobby GI, Holman AP, Iseman MD, Jones JM. Enumeration of tubercle bacilli in sputum of patients with pulmonary tuberculosis. Antimicrob Agents Chemother. 1973;4:94–104.CrossRefPubMedPubMedCentral Hobby GI, Holman AP, Iseman MD, Jones JM. Enumeration of tubercle bacilli in sputum of patients with pulmonary tuberculosis. Antimicrob Agents Chemother. 1973;4:94–104.CrossRefPubMedPubMedCentral
4.
go back to reference Kuaban C, Bame R, Mouangue L, Djella S, Yomgni C. Non Conversion Of Sputum Smears In New Smear Positive Pulmonary Tuberculosis Patients In Yaoundé, Cameroon. East Afr Med J. 2009;86 Suppl 5:219–25.PubMed Kuaban C, Bame R, Mouangue L, Djella S, Yomgni C. Non Conversion Of Sputum Smears In New Smear Positive Pulmonary Tuberculosis Patients In Yaoundé, Cameroon. East Afr Med J. 2009;86 Suppl 5:219–25.PubMed
5.
go back to reference Dominguez-Castellano A, Muniain MA, Rodriguez-Bano J, Garcia M, Rios MJ, Galvez J, et al. Factors associated with time to sputum smear conversion in active pulmonary tuberculosis. Int J Tuberc Lung Dis. 2003;7:432–8. PMID: 12757043.PubMed Dominguez-Castellano A, Muniain MA, Rodriguez-Bano J, Garcia M, Rios MJ, Galvez J, et al. Factors associated with time to sputum smear conversion in active pulmonary tuberculosis. Int J Tuberc Lung Dis. 2003;7:432–8. PMID: 12757043.PubMed
6.
go back to reference Pefura-Yone EW, Kengne AP, Kuaban C. Non-conversion of sputum culture among patients with smear positive pulmonary tuberculosis in Cameroon: a prospective cohort study. BMC Infect Dis. 2014;14:138.CrossRefPubMedPubMedCentral Pefura-Yone EW, Kengne AP, Kuaban C. Non-conversion of sputum culture among patients with smear positive pulmonary tuberculosis in Cameroon: a prospective cohort study. BMC Infect Dis. 2014;14:138.CrossRefPubMedPubMedCentral
7.
go back to reference Ukwaja KN, Oshi DC, Oshi SN, Alobu I. Profile and treatment outcome of smear positive TB patients who failed to smear convert after 2 months of treatment in Nigeria. Trans R Soc Trop Med Hyg. 2014;108(7):431–8.CrossRefPubMed Ukwaja KN, Oshi DC, Oshi SN, Alobu I. Profile and treatment outcome of smear positive TB patients who failed to smear convert after 2 months of treatment in Nigeria. Trans R Soc Trop Med Hyg. 2014;108(7):431–8.CrossRefPubMed
8.
go back to reference Salaniponi FML, Christensen JJ, Gausi F, Kwanjana JJ, Harries AD. Etat de la bacilloscopie à deux mois et résultat final subséquent du traitement chez les nouveaux patients atteints d’une tuberculose pulmonaire à bacilloscopie positive. Int J Tuberc Lung Dis. 1999;3(11):1047–9.PubMed Salaniponi FML, Christensen JJ, Gausi F, Kwanjana JJ, Harries AD. Etat de la bacilloscopie à deux mois et résultat final subséquent du traitement chez les nouveaux patients atteints d’une tuberculose pulmonaire à bacilloscopie positive. Int J Tuberc Lung Dis. 1999;3(11):1047–9.PubMed
9.
go back to reference Noubom M, Djouma NF, Donfack H, Kouomboua NPK, Tchasse T. Caracterisitiques des patients tuberculeux à l’ouest cameroun: 2000–2009. Pan Afr Med J. 2013;16:39. doi:10.11604/pamj.2013.16.39.2860.CrossRefPubMedPubMedCentral Noubom M, Djouma NF, Donfack H, Kouomboua NPK, Tchasse T. Caracterisitiques des patients tuberculeux à l’ouest cameroun: 2000–2009. Pan Afr Med J. 2013;16:39. doi:10.11604/pamj.2013.16.39.2860.CrossRefPubMedPubMedCentral
10.
go back to reference Jayakody W, Harries AD, Malhotra S. Characteristics and outcomes of tuberculosis patients who fail to smear convert at two months in Sri Lanka. Public Health Action. 2013;3:26–30. doi:10.5588/pha.12.0090.CrossRefPubMedPubMedCentral Jayakody W, Harries AD, Malhotra S. Characteristics and outcomes of tuberculosis patients who fail to smear convert at two months in Sri Lanka. Public Health Action. 2013;3:26–30. doi:10.5588/pha.12.0090.CrossRefPubMedPubMedCentral
11.
go back to reference Singla R, Osman MM, Khan N. Factors predicting sputum smear positivity among pulmonary tuberculosis patients 2 months after treatment. Int J Tuberc Lung Dis. 2003;7:58–64.PubMed Singla R, Osman MM, Khan N. Factors predicting sputum smear positivity among pulmonary tuberculosis patients 2 months after treatment. Int J Tuberc Lung Dis. 2003;7:58–64.PubMed
12.
go back to reference Parikh R, Nataraj G, Kanade S. Time to sputum conversion in smear positive pulmonary TB patients on Category 1 DOTS and factors delaying it. J Assoc Physicians India. 2012;60:22–6.PubMed Parikh R, Nataraj G, Kanade S. Time to sputum conversion in smear positive pulmonary TB patients on Category 1 DOTS and factors delaying it. J Assoc Physicians India. 2012;60:22–6.PubMed
13.
go back to reference Kuyp VF, Mahan CS. Prolonged positivity of sputum smears with negative cultures during treatment for pulmonary tuberculosis. Int J Tuberc Lung Dis. 2012;16:1663–7.CrossRefPubMed Kuyp VF, Mahan CS. Prolonged positivity of sputum smears with negative cultures during treatment for pulmonary tuberculosis. Int J Tuberc Lung Dis. 2012;16:1663–7.CrossRefPubMed
15.
go back to reference Tiwari S, Kumar A, Kapoor SK. Relationship between sputum smear grading and smear conversion rate and treatment outcome in the patients of pulmonary tuberculosis undergoing dots: a prospective cohort study. Indian J Tuberc. 2012;59 Suppl 3:135–40.PubMed Tiwari S, Kumar A, Kapoor SK. Relationship between sputum smear grading and smear conversion rate and treatment outcome in the patients of pulmonary tuberculosis undergoing dots: a prospective cohort study. Indian J Tuberc. 2012;59 Suppl 3:135–40.PubMed
16.
go back to reference Rekha VVB, Balasubramanian R, Swaminathan S, Rahman RRF, Sundaram V, Thyagarajan K, et al. Sputum conversion at the end of intensive phase of Category-1regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV Infection: An analysis of risk factors. Indian J Med Res. 2007;126:452–8. Rekha VVB, Balasubramanian R, Swaminathan S, Rahman RRF, Sundaram V, Thyagarajan K, et al. Sputum conversion at the end of intensive phase of Category-1regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV Infection: An analysis of risk factors. Indian J Med Res. 2007;126:452–8.
17.
go back to reference Fanai S, Viney K, Tarivonda L, Roseveare C, Tagaro M, Marais BJ. Profile of tuberculosis patients with delayed sputum smear conversion in the Pacific island of Vanuatu. Public Health Action. 2014;4 Suppl 1:19–24.CrossRef Fanai S, Viney K, Tarivonda L, Roseveare C, Tagaro M, Marais BJ. Profile of tuberculosis patients with delayed sputum smear conversion in the Pacific island of Vanuatu. Public Health Action. 2014;4 Suppl 1:19–24.CrossRef
18.
go back to reference Lee J, Lee BJ, Yoon HI, Lee C-T, Lee JH. Influence of previous tuberculosis treatment history on acid-fast bacilli smear and culture conversion. Int J Tuberc Lung Dis. 2012;16 Suppl 10:1344–8.CrossRefPubMed Lee J, Lee BJ, Yoon HI, Lee C-T, Lee JH. Influence of previous tuberculosis treatment history on acid-fast bacilli smear and culture conversion. Int J Tuberc Lung Dis. 2012;16 Suppl 10:1344–8.CrossRefPubMed
19.
go back to reference Feng-Zeng Z, Levy MH, Sumin W. Sputum microscopy results at two and three months predict outcome of tuberculosis treatment. Int J Tuberc Lung Dis. 1997;1 Suppl 6:570–2. Feng-Zeng Z, Levy MH, Sumin W. Sputum microscopy results at two and three months predict outcome of tuberculosis treatment. Int J Tuberc Lung Dis. 1997;1 Suppl 6:570–2.
20.
go back to reference Rieder HL. Sputum smear conversion during directly observed treatment for tuberculosis. Tuber Lung Dis. 1996;77 Suppl 2:124–9.CrossRefPubMed Rieder HL. Sputum smear conversion during directly observed treatment for tuberculosis. Tuber Lung Dis. 1996;77 Suppl 2:124–9.CrossRefPubMed
21.
go back to reference Lienhardt C, Manneh K, Bouchier V, Lahai G, Milligan PJM, McAdam KPWJ. Factors determining the outcome of treatment of adult smear-positive tuberculosis cases in the Gambia. Int J Tuberc Lung Dis. 1998;2 Suppl 9:712–8.PubMed Lienhardt C, Manneh K, Bouchier V, Lahai G, Milligan PJM, McAdam KPWJ. Factors determining the outcome of treatment of adult smear-positive tuberculosis cases in the Gambia. Int J Tuberc Lung Dis. 1998;2 Suppl 9:712–8.PubMed
22.
go back to reference Schmaltz CAS, Santoro-Lopes G, Lourenc MC, Morgado MG, Velasque LS. Factors Impacting Early Mortality in Tuberculosis/HIV Patients: Differences between Subjects Naïve to and Previously Started on HAART. PLoS One. 2012;7 Suppl 9:e45704. doi:10.1371/journal.pone.0045704.CrossRefPubMedPubMedCentral Schmaltz CAS, Santoro-Lopes G, Lourenc MC, Morgado MG, Velasque LS. Factors Impacting Early Mortality in Tuberculosis/HIV Patients: Differences between Subjects Naïve to and Previously Started on HAART. PLoS One. 2012;7 Suppl 9:e45704. doi:10.1371/journal.pone.0045704.CrossRefPubMedPubMedCentral
23.
go back to reference Dodor EA. Tuberculosis treatment default at the Communicable Diseases Unit of Effia-Nkwanta Regional Hospital: a 2 year experience. Int J Tuberc Lung Dis. 2004;8:1337–41.PubMed Dodor EA. Tuberculosis treatment default at the Communicable Diseases Unit of Effia-Nkwanta Regional Hospital: a 2 year experience. Int J Tuberc Lung Dis. 2004;8:1337–41.PubMed
Metadata
Title
Delay in sputum smear conversion and outcomes of smear-positive tuberculosis patients: a retrospective cohort study in Bafoussam, Cameroon
Authors
Fabrice Nembot Djouma
Michel Noubom
Jérôme Ateudjieu
Hubert Donfack
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2015
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-015-0876-1

Other articles of this Issue 1/2015

BMC Infectious Diseases 1/2015 Go to the issue